Voloridge Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.7M Buy
167,934
+62,797
+60% +$13.7M 0.14% 191
2025
Q1
$23.5M Buy
+105,137
New +$23.5M 0.09% 309
2024
Q4
Sell
-146,402
Closed -$43.9M 1410
2024
Q3
$43.9M Buy
146,402
+88,712
+154% +$26.6M 0.16% 187
2024
Q2
$19M Buy
+57,690
New +$19M 0.07% 383
2024
Q1
Sell
-738
Closed -$260K 1381
2023
Q4
$260K Sell
738
-16,620
-96% -$5.85M ﹤0.01% 1091
2023
Q3
$6.51M Sell
17,358
-25,840
-60% -$9.7M 0.03% 578
2023
Q2
$16.5M Buy
+43,198
New +$16.5M 0.08% 336
2023
Q1
Sell
-144,650
Closed -$34M 1647
2022
Q4
$34M Buy
144,650
+136,156
+1,603% +$32M 0.19% 153
2022
Q3
$2.09M Sell
8,494
-90,518
-91% -$22.3M 0.01% 974
2022
Q2
$29.9M Buy
99,012
+27,584
+39% +$8.34M 0.15% 192
2022
Q1
$29.3M Sell
71,428
-9,642
-12% -$3.96M 0.17% 169
2021
Q4
$38M Buy
81,070
+49,879
+160% +$23.4M 0.21% 122
2021
Q3
$13.2M Buy
31,191
+13,341
+75% +$5.66M 0.09% 330
2021
Q2
$6.41M Sell
17,850
-4,812
-21% -$1.73M 0.04% 552
2021
Q1
$6.39M Sell
22,662
-16,104
-42% -$4.54M 0.05% 454
2020
Q4
$11M Buy
38,766
+37,841
+4,091% +$10.7M 0.09% 254
2020
Q3
$254K Buy
+925
New +$254K ﹤0.01% 1172
2020
Q2
Sell
-3,967
Closed -$604K 1529
2020
Q1
$604K Sell
3,967
-5,500
-58% -$837K 0.02% 651
2019
Q4
$1.42M Sell
9,467
-8,296
-47% -$1.25M 0.03% 563
2019
Q3
$2.52M Sell
17,763
-8,153
-31% -$1.16M 0.04% 392
2019
Q2
$3.24M Buy
25,916
+17,384
+204% +$2.18M 0.09% 234
2019
Q1
$940K Buy
+8,532
New +$940K 0.03% 499
2018
Q1
Sell
-2,869
Closed -$283K 679
2017
Q4
$283K Buy
+2,869
New +$283K 0.01% 450
2017
Q3
Sell
-59,870
Closed -$5.66M 546
2017
Q2
$5.66M Buy
+59,870
New +$5.66M 0.14% 160